Results 11 to 20 of about 7,297 (209)
Teprotumumab for Thyroid-Associated Ophthalmopathy [PDF]
New England Journal of Medicine, 2017 BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns ...
Antonelli, A +18 more
core +8 more sources
Thyroid-associated Ophthalmopathy
Türk Oftalmoloji Dergisi, 2017 Thyroid-associated ophthalmopathy is the most frequent extrathyroidal involvement of Graves’ disease but it sometimes occurs in euthyroid or hypothyroid patients.
Esra Şahlı, Kaan Gündüz
doaj +3 more sources
Cytokines in Thyroid-Associated Ophthalmopathy
Journal of Immunology Research, 2022 Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves’ orbitopathy (GO), is a complex autoimmune condition causing visual impairment, disfigurement, and harm to patients’ physical and mental health.
Pengbo Zhang, Huang Zhu
doaj +4 more sources
THYROID ASSOCIATED OPHTHALMOPATHY – A REVIEW [PDF]
Malaysian Family Physician, 2009 Thyroid associated ophthalmopathy is an autoimmune disorder affecting the orbital and periorbital tissues. Hyperthyroidism is commonly associated with thyroid associated ophthalmopathy, however in 5% to 10% of cases it is euthyroid.
CHONG MS +6 more
doaj +2 more sources
Thyroid-Associated Ophthalmopathy in Iranian Patients [PDF]
Acta Medica Iranica, 2011 We determined the frequency of clinical thyroid ophthalmopathy in Iranian patients. This crosssectional study was performed at the Endocrinology Institute of Tehran University of Medical Sciences.
Mohsen Bahmani Kashkouli +6 more
doaj +3 more sources
Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
Frontiers in Endocrinology, 2022 Thyroid associated ophthalmopathy (TAO) is a common extra-thyroid clinical manifestation of Graves’ disease. It is an inflammatory disease of the eye and orbital tissues.
Tianyu Dong, Zhujun Fu, Xu Wang
doaj +3 more sources
Glymphatic System Dysfunction in Thyroid-Associated Ophthalmopathy: A Multimodal MRI Study. [PDF]
CNS Neurosci TherTAO patients exhibit impaired glymphatic function, with reduced DTI‐ALPS indices and gBOLD‐CSF coupling, but unchanged choroid plexus volume. These alterations correlate with neuropsychological symptoms and sleep disturbances. Restoring glymphatic activity may offer a therapeutic approach to enhance patient outcomes.
Zhang L, Yao J, Qi Y, Luo Y, Liu J.
europepmc +2 more sources
Clinical application of cone beam CT in intensity-modulated radiotherapy for the moderate to severe thyroid-associated ophthalmopathy. [PDF]
J Appl Clin Med PhysAbstract Background Cone beam CT (CBCT) has been reported for intensity‐modulated radiation therapy (IMRT) of various cancers due to its real‐time imaging capabilities, but studies on its application in orbital diseases, particularly moderate to severe thyroid‐associated ophthalmopathy (TAO), remain limited.
Kang D, Hu H, Ma S, Bin S.
europepmc +2 more sources
BMC Ophthalmology, 2021 Purpose A new radiological method was used to evaluate the plastic effect of modified transconjunctival orbital fat decompression surgery in patients with inactive thyroid-associated ophthalmopathy.
Bei Li +4 more
doaj +1 more source
Thyroid dermopathy responds to teprotumumab therapy
Endocrinology, Diabetes & Metabolism Case Reports, 2022 Thyroid dermopathy is an uncommon manifestation of thyroid disease that impairs the quality of life in certain cases. Currently, the available treatments offer limited results and a chance of recurrence.
Ricaurte Crespo-Trevino +6 more
doaj +1 more source